Cited by 104Advanced Nanomaterials in CatalysisNanoparticle-Based Drug DeliveryNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke

Abstract

Overproduction of reactive oxygen species by damaged mitochondria after ischemia is a key factor in the subsequent cascade of damage. Delivery of therapeutic agents to the mitochondria of damaged neurons in the brain is a potentially promising targeted therapeutic strategy for the treatment of ischemic stroke. In this study, we developed a ceria nanoenzymes synergistic drug-carrying nanosystem targeting mitochondria to address multiple factors of ischemic stroke. Each component of this nanosystem works individually as well as synergistically, resulting in a comprehensive therapy. Alleviation of oxidative stress and modulation of the mitochondrial microenvironment into a favorable state for ischemic tolerance are combined to restore the ischemic microenvironment by bridging mitochondrial and multiple injuries. This work also revealed the detailed mechanisms by which the proposed nanodelivery system protects the brain, which represents a paradigm shift in ischemic stroke treatment.

Overview

Integrity signals

Registry

Crossref · 10.1021/acsnano.3c10982

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. 10.1016/S0140-6736(18)31269-8 · DOI
  2. 10.1056/NEJMcp1917030 · DOI
  3. 10.1161/STROKEAHA.120.032810 · DOI
  4. 10.1001/jamaneurol.2016.5823 · DOI
  5. 10.1021/acsnano.9b01798 · DOI
  6. 10.1021/acsnano.1c00672 · DOI
  7. 10.1056/NEJMoa1411587 · DOI
  8. 10.1161/STROKEAHA.120.031197 · DOI
  9. 10.1038/s41401-020-00583-3 · DOI
  10. 10.1161/STROKEAHA.120.033272 · DOI
  11. 10.1016/j.apsb.2023.06.011 · DOI
  12. 10.14336/AD.2017.1126 · DOI
  13. 10.4103/bc.bc_14_18 · DOI
  14. 10.1021/acsnano.5b08045 · DOI
  15. 10.1038/s41580-019-0173-8 · DOI
  16. 10.1021/acs.molpharmaceut.2c00383 · DOI
  17. 10.1038/s41392-022-01064-1 · DOI
  18. 10.1002/adma.202201322 · DOI
  19. 10.1021/acsnano.1c04753 · DOI
  20. 10.1016/j.jconrel.2023.05.009 · DOI
  21. 10.1021/jacs.0c03805 · DOI
  22. 10.1021/acsnano.8b00999 · DOI
  23. 10.1021/acsnano.2c03422 · DOI
  24. 10.1021/acs.nanolett.0c01371 · DOI
  25. 10.1002/adma.202210144 · DOI
  26. 10.1021/acsnano.2c11363 · DOI
  27. 10.1021/jacs.3c07048 · DOI
  28. 10.1021/acsnano.1c07205 · DOI
  29. 10.1016/j.lfs.2021.119500 · DOI
  30. 10.1038/s41467-021-21714-2 · DOI
  31. 10.1002/adma.201807965 · DOI
  32. 10.1021/acschemneuro.1c00847 · DOI
  33. 10.1021/acsnano.1c05272 · DOI
  34. 10.1002/anie.201802309 · DOI · Paper page
  35. 10.1002/anie.202305576 · DOI
  36. 10.1002/adma.201807965 · DOI
  37. 10.1002/anie.201203780 · DOI
  38. 10.1016/j.phrs.2020.105078 · DOI
  39. 10.1002/trc2.12242 · DOI
  40. 10.1039/C7NR02193C · DOI
  41. 10.7150/thno.15433 · DOI
  42. 10.1021/acsnano.3c01497 · DOI
  43. 10.1021/acs.nanolett.1c00231 · DOI
  44. 10.1126/sciadv.aay9751 · DOI
  45. 10.1021/acs.nanolett.9b04974 · DOI
  46. 10.1016/j.jconrel.2022.03.001 · DOI
  47. 10.1016/j.cell.2015.10.001 · DOI · Paper page
  48. 10.1002/ange.202003895 · DOI
  49. 10.1038/s41580-020-0210-7 · DOI · Paper page
  50. 10.1002/adma.202006570 · DOI
  51. 10.1002/advs.202101526 · DOI
  52. 10.1002/adfm.202212326 · DOI
  53. 10.1021/acsnano.8b04787 · DOI
  54. 10.1002/advs.202306156 · DOI
  55. 10.1002/adfm.202212919 · DOI
  56. 10.1186/s12974-019-1516-2 · DOI
  57. 10.1111/febs.16297 · DOI

Cited by

Sorted by citations

Metadata

Authors
Liao, J., Li, Y., Fan, L., Sun, Y., Gu, Z., Xu, Q.-Q., Wang, Y., Xiong, L., Xiao, K., Chen, Z.-S., Ma, Z., Zhang, C., Wang, T., & Lu, Y.
Affiliations
  • Shanghai University (CN)
  • Second Military Medical University (CN)
  • St. John's University (US)
  • ShanghaiTech University (CN)
  • Department of Pharmaceutical Sciences, School of Pharmacy, Naval Medical University, Shanghai, 200433, China
Corresponding author
  • Ma, Zhiwei
  • Zhang, Chuan
  • Wang, Tingfang
Venue
ACS Nano
Published
2024-01-24
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W4391160872
Cited by
104
References
1
Citations by year
2026: 28 · 2025: 51 · 2024: 25
FWCI
9.30
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Nano (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Natural Science Foundation of Shanghai Municipality (20ZR1420000, 20ZR1470300)
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (21S21902100)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords
ischemic stroke, ischemia-reperfusion injury, mitochondrial targeting, reactive oxygen species, oxidative stress, ischemic tolerance, neuroprotection, synergistic therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review